Filter your results
- 5
- 5
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 5
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 5
- 5
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
The Sec61 translocon is a therapeutic vulnerability in multiple myelomaEMBO Molecular Medicine, 2022, Online ahead of print., pp.e14740. ⟨10.15252/emmm.202114740⟩
Journal articles
pasteur-03534527v1
|
||
|
Shaping mycolactone for therapeutic use against inflammatory disordersScience Translational Medicine, 2015, 7 (289), pp.289ra85 - 289ra85. ⟨10.1126/scitranslmed.aab0458⟩
Journal articles
pasteur-01382767v1
|
||
|
Ipomoeassin F Binds Sec61α to Inhibit Protein TranslocationJournal of the American Chemical Society, 2019, 141 (21), pp.8450-8461. ⟨10.1021/jacs.8b13506⟩
Journal articles
hal-02323236v1
|
||
|
Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJNature Communications, 2020, 11 (1), pp.5239. ⟨10.1038/s41467-020-19060-w⟩
Journal articles
pasteur-03262335v1
|
||
|
Mycolactone subverts immunity by selectively blocking the Sec61 translocon.Journal of Experimental Medicine, 2016, 213 (13), pp.2885-2896. ⟨10.1084/jem.20160662⟩
Journal articles
pasteur-01432024v1
|